Are we at the Goal Line with the Novel Oral Anticoagulants and Have We Reached the End of the Line for Dronedarone and Vernakalant – or is There More to Come?期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Are we at the Goal Line with the Novel Oral Anticoagulants and Have We Reached the End of the Line for Dronedarone and Vernakalant – or is There More to Come?

Authors:	James A Reiffel

Institution:	Columbia University, Medical Center, New York, NY, USA

Abstract:

Keywords:	Atrial fibrillation anticoagulation antiarrhythmic drugs dronedarone NOACs ranolazine vernakalant